This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Edited by Michael R. Trimble, 272 pp, with illus, $65, New York, NY, John Wiley & Sons Inc, 1989.

Jack D. Grabow, MD, Reviewer
Rochester, Minn

Arch Neurol. 1992;49(12):1225.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The focus of this book is "chronic" epilepsy, and it is concerned with the 20% to 40% of patients with epilepsy who have recurrent seizures despite treatment with antiepileptic drugs. The topics covered in the 18 chapters include pathophysiology, prognosis, monitoring, imaging, syndromes in children, cognitive hazards, social difficulties, behavioral consequences, strategies of treatment with antiepileptic drugs, management of children, a surgical treatment, epidemiology in developing countries, and genetics. Although most of the authors are associated with well-known medical institutions in London, England, an international approach is provided by including authors from Germany, Ireland, Canada, and the United States.

Clobazam (Frizium), an antiepileptic drug not available in the United States, is discussed in three chapters. Because this drug is available in Canada and Mexico, readers in the United States who practice near the borders of these countries may want to be familiar with its use in adjunctive therapy.

This book . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?